Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...

A growing number of people are turning to medications like Ozempic, Wegovy, and Mounjaro to aid in weight loss and manage ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.